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Abstract.  The effect of leukoregulin,  a 50-kD lym- 
phokine with unique antitumor properties,  was studied 
in vitro on several fibroblast functions.  Leukoregulin 
did not inhibit fibroblast proliferation,  as measured by 
cell enumeration and  [3H]thymidine incorporation,  and 
had no cytotoxic effect in terms of increased mem- 
brane permeability detected by trypan blue exclusion, 
two of the major leukoregulin actions on tumor cells. 
Leukoregulin induced a dose-dependent decrease in 
collagen synthesis, demonstrated by decreased [3H]pro- 
line incorporation into collagenase-digestible protein, 
as early as 6 h after the addition of the lymphokine to 
human fibroblasts. Leukoregulin inhibited the synthesis 
of both type I and type HI collagen, as measured by 
SDS-PAGE and by specific radioimmunoassay.  Neu- 
tralizing  antibodies to interleukin-la,  interleukin-1/~, 
tumor necrosis factor-a, and interferon-3,  failed to al- 
ter the effect of leukoregulin on collagen synthesis, at- 
testing that leukoregulin action was not due to con- 
tamination  by these cytokines. Inhibition of collagen 
synthesis occurred concomitantly with increased secre- 
tion of prostaglandin  F_,2 and a transient rise in intra- 
cellular cyclic AMP content, peaking at 6 h.  However, 
blocking prostaglandin  synthesis with indomethacin 
did not counteract inhibition of collagen synthesis by 
leukoregulin,  demonstrating  independence of this ac- 
tion of leukoregulin from cyclooxygenase metabolites. 
Leukoregulin also stimulated glycosaminoglycan 
production in a dose-dependent manner,  affecting the 
synthesis of hyaluronic acid as the major fibroblast- 
derived extracellular glycosaminoglycan. In addition, 
secretion of neutral proteases (collagenase, elastase, 
caseinase) was increased.  These observations indicate 
that leukoregulin is able to regulate synthesis of mole- 
cules critical to the deposition of the extracellular ma- 
trix by nontransformed nonmalignant  fibroblasts. 
EtrKOREGULIr~ (LR)  1 is a lymphokine synthesized  and 
secreted by activated human lymphocytes, that inhib- 
its proliferation  of and kills  tumor cells,  increases 
their sensitivity to natural killer lymphocyte cytotoxicity and 
produces a rapid and reversible increase in tumor cell mem- 
brane permeability (Ransom et al., 1985; Barnett and Evans, 
1986; Evans et al., 1987). LR is a glycoprotein with a molec- 
ular size of ~50 kD and several isoelectric forms, one with 
a pI near 5.1 and another near 7.0 (Evans et al., 1989). Unlike 
many  other  lymphokines,  which  primarily  regulate  cells 
within  the immune system,  LR has no identified  immuno- 
regulatory role for cells in the normal immune system.  In- 
stead, LR prevents carcinogen-  and radiation-induced  trans- 
formation of normal cells and has cytostatic and cytotoxic 
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lin; PGE2, prostaglandin E2; Suc(Ala)3 NA, suceinyl trialanine paranitro- 
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actions on abnormal target cells as part of its anticancer  ac- 
tion  (reviewed in Evans,  1987). 
Fibroblasts are mesenchymal cells that play a critical role 
in embryonic morphogenesis,  would repair,  and tissue re- 
modeling  by synthesizing  and organizing  connective tissue 
components.  It is  well established that fibroblasts  do not 
function  autonomously but, instead,  respond to numerous 
molecular signals  from different  cells of the immune sys- 
tem (e.g., T lymphocytes, macrophages,  platelets) and other 
sources (reviewed  in  Postlethwaite  and Kang,  1988).  Nu- 
merous  soluble  leukocytic  mediators  including  interleu- 
kin-1 (IL-1), tumor necrosis factor-a (TNF-o0,  interferon- 
"y (IFN-3,),  and transforming  growth  factor-/3 (TGF-/~) are 
present in the sites of chronic inflammation  or would heal- 
ing, that have been infiltrated  by leukocytes. The ability of 
these cytokines to modify connective tissue cell metabolism 
has been well documented, both in vitro and  in vivo (re- 
viewed in Postlethwaite and Kang,  1988; Freundlich et al., 
1986). However, a number of studies suggest that other still 
undefined  factors are involved with a balance between sev- 
eral cytokines controlling  fibroblast recruitment and matrix 
deposition during  wound healing.  At the present time,  it is 
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no study has examined if LR has a role in the regulation of  ~  16-  _~ 
fibroblast function.  ~  14- 
The control of extracellular matrix (ECM) turnover in-  ÷ ~' 
volves both deposition of structural components such as col-  -~ $  12- 
lagen, fibronectin, and proteoglycans, and their degradation  ~  " 
by secreted proteases. In this work, we report that LR modu-  ~ _~ 
lates the synthesis of matrix components, inhibiting collagen  ~ "[  s. 
and  increasing  glycosaminoglycan  production.  This  effect  ~  ~  6. 
is  paralleled  by  an  increase  in  extracellular  collagenase,  ~ 
elastase and neutral protease activities, a transient rise in  ~  ~ ~  ~"  4. 
intracellular cyclic AMP and a release of prostaglandin E2  ~ ~  2. 
(PGE2).  These LR-induced changes  in fibroblast metabo- 
lism occur without change in cell proliferation or plasma  ~.  0 
membrane permeability and indicate the potential of LR to 
regulate fibroblast function. 
Materials and Methods 
Cell Cultures 
Fibroblasts obtained from explanted infant foreskins  were grown in Dul- 
becco's  modified  of Eagle's  medium (DMEM; Gibco, Paisley,  UK) sup- 
plemented with antibiotics (100 IU/ml penicillin, 100 ~,g/ml streptomycin, 
and 0.25  #g/ml fungizone)  and 10% heat-inactivated  FCS (Gibco).  The 
cells were grown in a  5 % CO2 atmosphere and experiments were per- 
formed on different cell strains between fourth and eighth passage. 
Leukoregulin Preparation 
Leukoregulin  with a pI of 5.1 and a molecular mass of 50 kD was purified 
from human peripheral blood leukocytes as previously described (Evans et 
al.,  1989).  In brief,  normal human lymphocytes  were  stimulated  with 
phytohaemagglutinin (leukoagglutinin  isomer;  Sigma Chemical Co.,  St. 
Louis, MO), for 48 h and LR was purified using sequential  diafiltration, 
anion exchange, isoelectric focusing and high performance molecular siev- 
ing liquid chromatography.  1 U of LR equals that amount causing a 50% 
increase in the plasma membrane permeability of 1 ×  106 K562 erythro- 
leukemia cells/m1 during a 2-h period (Barnett and Evans, 1986). 
Experimental Procedure 
For the experiments on confluent cultures,  cells were seeded at a density 
of 2  ×  104 cells/cm  2  and allowed to grow to confluency (5-6 d). To study 
the production of collagen,  the cultures were preincubated for 24 h  in 
DMEM  supplemented with 2%  FCS  and 50  #g/ml  sodium  ascorbate 
(Sigma Chemical Co.).  Then the media were removed and fresh medium 
containing 50 #g/ml/3-aminopropionitrile ~-APN; Sigma Chemical Co.) 
was added, with or without LR. The media were collected at different time 
points for prostaglandin F~ assay, and the corresponding cell layers were 
used for cyclic AMP determination. Estimation of total collagen production 
was performed in 2-cm  2 dishes with 0.5 ml medium, in the presence of 
2  #Ci/ml  [3H]proline  (CEA,  France,  30-40 Ci/mmol) as a  radioactive 
precursor.  For determination of the amounts of type I and type HI collagen 
and fibronectin  by SDS-PAGE, radiolabeling was performed with 20 #Ci/mi 
[3H]proline in 25-cm  2 flasks (3 nd medium). 
2  Total gly~ycan  (GAG) synthesis was estimated in 2-cm  dishes, 
using 2.5  ~,Ci/ml [~H]glucosamine  (11 Ci/mmol; CEA,  Saclay, France) 
and 5 #Ci/ml [35S] SO4 (25 Ci/mg; Amersham International, Amersham, 
UK) as radioactive precursors, with no ascorbate and/~-APN in the preincu- 
bation and incubation media. 
Collagenase,  elastase and neutral proteases activities were either assayed 
in the media from 75-cm  2 flasks (6 ml) or from 9.6-cm  2 dishes after 24-h 
incubation periods, in the absence of serum. 
[3H]thymidine  incorporation was  estimated in cells grown in 2-cm  2 
dishes. 
For the experiments on proliferating ceils,  fibroblasts  were seeded at a 
density of 5  ×  104 cells/9.6 cm  2 and allowed to grow for 4 d before prein- 
cubation. 
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Figure  1.  Effect of leukoregulin on collagen and noncollagenous 
protein synthesis by human dermal fibroblasts. Confluent cells were 
labeled for 24 h  with [3H]proline in the presence of varying con- 
centrations of LR, as described in Materials and Methods. Colla- 
gen radioactivity was estimated as dpm in collagenase digestible 
material present in the culture medium (A). Noncollagenous pro- 
tein represents the amount of radioactivity remaining after col- 
lagenase digestion (B). Results expressed as dpm  x  10-3/dish are 
the mean ±  SD of quadruplicate assays, a, P  <  0.05; b, P  <  0.02; 
c,  P  <  0.01;  d,  P  <  0.001. 
Collagen Production 
Assay of Radioactive Collagen. Newly synthesized  collagen  was assayed 
in the culture medium as collagenase  sensitive material (Peterkofsky  and 
Diegelmann, 1971). We have previously shown that >90 % of the newly syn- 
thesized collagen  was recovered  in the medium when fibroblasts  are in- 
cubated with ascorbate and/3-aminopropionitrile. The amount of noncol- 
lagenous  protein was  estimated from  the radioactivity remaining after 
collagenase  digestion  (Advance Biofacture Corp., Lynnbrook, NY). 
Polyacrylamide Gel Electrophoresis. Confluent cultures were first prein- 
cubated as described above and then pulsed with 20 #Ci/rni [3H]proline in 
absence or in presence of 0.1,  1, and 5  U/ml LR for 24 h. SDS-PAGE and 
subsequent fluorography  of collagen and procollagen chains were  per- 
formed as previously  described (Mauviel et al.,  1991). Interrupted elec- 
trophoresis was used to separate type I and type HI collagen chains (Sykes 
et al.,  1976). 
Radioimmunoassay of ~es I and III Collagens. RIA of collagens type 
I and type HI were performed in the culture media as described (Magloire 
et al., 1986) using specific antibodies against human type I and type HI col- 
lagens. 
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PAGE analysis of  extracellular 
proteins synthesized in control 
and  leukoregulin-treated  hu- 
man dermal fibroblasts.  Con- 
fluent  cells  were  labeled  for 
24  h  with  [3H]proline  as de- 
scribed in Materials and Meth- 
ods, in the absence or presence 
of 0.1,  1, and 5 U/ml LR. Pro- 
teins  from the  medium  were 
separated  electrophoretically 
in  6%  acrylamide  gels  con- 
taining  SDS  and  2  M  urea, 
with (A) or without (B) pep- 
sin  digestion.  Reduction  of 
collagen type I~ trimers with 
mercaptoethanol  (0.1 M)  oc- 
curred  during  interruption 
of the electrophoresis.  Bands 
corresponding  to  procolla- 
gens, collagens, and fibronec- 
tin chains are indicated. 
Glycosaminoglycan Production 
Assay of Total Labeled  Glycosaminoglycans.  The total amount of labeled 
GAG was estimated by precipitation of media and cell extracts with cetyl- 
pyridinium chloride (1% [wt/vol]; Merck, Darmstadt, Germany)and etha- 
nol (5 vol) as previously described (Wasteson et al., 1976). The final pellet 
was dissolved in 0.5 ml 75 mM NaC1 and the radioactivity  of an aliquot 
was assayed by liquid scintillation counting. 
Ion-exchange Chromatography of Labeled Proteoglycans. 25-cm 2 
flasks of confluent fibroblast cultures were labeled for 24 h with [3H]glu- 
cosamine  (2.5 #Ci/ml) and  [35S]sulfate (5 #Ci/ml) in presence  or in ab- 
sence of LR (1 U/ml). Proteoglycans extracted by 4 M guanidinium-HCl 
(Ongema et al., 1975) from cell layers and media,  were dialyzed for 24 h 
at 4°C against 0.1 M Tris-HCl, 7 M urea pH 7.5 containing 50 mM EDTA, 
1 mM PMSF, 10 mM N-ethylmaleimide, 100 mM 6-aminohexanoic acid, 
and 10 mM benzaminidium chloride (Sigma Chemical Co.) as protease in- 
hibitors. Then the samples were applied to a 1 x  10 cm DEAE-Sephacel 
column (Pharmacia,  Uppsala,  Sweden) equilibrated with the same buffer. 
The cohmm was washed with 15 rrd of the buffer and eluted with a linear 
0-1 M NaCI gradient.  Fractions  of 0.4 ml were collected and assayed by 
liquid scintillation counting. 
Protease Assays 
Substrate  Gels.  For  visual  localization and determination  of molecular 
masses of bands with enzyme activity, aliquots of culture medium (50/~1) 
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IL-la, IL-1/~, or IFN-T on Leukoregulin-induced Inhibition 
of Fibroblast Collagen Synthesis 
Collagen 
Noncollagenous  (dpm [3H]proline 
protein (dpm [3H]-  +  dpm [3HI- 
proline/dish)  hydroxyproline/dish) 
Control  7,163  +  395  (100)  11,287  +  1,132  (100) 
LR (1  U/ml)  5,621  +  308* (78)  5,492  +  833* (49) 
TNF-c~ (10 ng/ml)  5,057  5- 324* (71)  5,636  +  522* (50) 
Anti-TNF-c~  6,244  5:  220§  (87)  9,586  5-  1,1984  (85) 
(50 t~g/ml) 
TNF-~ + anti-TNF-c~  6,201 5: 377§ (87)  9,824 5- 4004 (87) 
LR + anti-TNF-c~  4,627 5: 263* (65)  5,043 5: 352* (45) 
IL-Icx  (I0 U/ml)  6,002 5: 418" (84)  7,000 5- 270* (62) 
Anti-IL-hx  6,254 5: 51D (87) 10,491 5- I,I194  (93) 
(  I00 ~g/ml) 
IL-la + anti-IL-~  7,504 5- 5084 (105) 9,525 5: 70D (84) 
LR + anti-IL-1o~  6,556 ± 3204 (92)  6,446 5- 57011  (57) 
IL-13 (10 U/ml)  6,169 5: 398* (86)  7,881 5: 898* (70) 
Anti-IL-1~  6,722 5:4094 (94) 10,168 5:4574 (90) 
(ioo ~g/ml) 
IL-I~ + anti-IL-IB  6,796 ± 5391 (95) 10,468 5:8884 (93) 
LR + anti-IL-13  5,622 ±  1764  (78)  6,656 + 77511  (59) 
IFN-~, (10' U/ml)  4,752 5: 619, (66)  4,561 5- 170' (40) 
Anti-IFN-~  7,936 5:8104 O11) 11,962 5:1,0124 (106) 
(1:100 dilution) 
IFN-3,  +  anti-IFN-~  6,642  5:9134  (93)  8,643  5:  745* (77) 
LR  +  anti-IFN--y  6,253  5- 5274  (87)  6,184  +  70111 (55) 
Collagen  synthesis was measured by 3[H]-proline incorporation  after 24-h in- 
cubation as described in Materials  and Methods. Results are the mean -t- SD 
of quadruplicate  assays. Numbers in brackets correspond to the percentage of 
control. 
* P <  0.05. 
P < 0.001. 
4 Not significant. 
II  P <  0.01. 
were electrophoresed on SDS-substrate gels containing 1 mg/ml of gelatin 
(Overall et al., 1989). After removal of SDS with Triton X-100, neutral pro- 
tease activity was revealed by incubation of  the gels for 48 h at 37°C in 0.1 M 
Tris-HCl buffer, pH 7.4 containing 10 mM CaCI2,  followed by staining in 
0.5% Coomassie blue in 30% propanol-2/10% acetic acid and destaining 
in 5% methanol/7.5% acetic acid. 
Elastase Activity.  Succinyl trialanine paranitroalanine (Suc(AIa)3NA) 
was used as a synthetic substrate for the determination of elastase activity 
(Szendroi et al.,  1984).  Enzyme units are defined as nmol of nitroalanine 
released per hour, assuming a molar extinction coefficient of EM =  8,800. 
Collagenase  and Caseinase Acaviaes.  Collagenase and caseinase ac- 
tivities were assayed using 3H-acetylated collagen (1  mg/ml,  1.9  ×  10  ~ 
cpm/mg) and 3H-acetylated casein (1 mg/ml, 1.13 ×  106 cpm/mg) as sub- 
strates (Cawston and Barrett,  1977). 
Prostaglandin E2 Assay 
PGE2 was assayed in the culture medium by specific radioimmunoassay 
(Dray et al., 1975) with antiserum from Institut Pasteur Production (Marnes 
la Coquette, France). 
Cyclic AMP Assay 
After incubation, the cells were washed three times with cold PBS and kept 
overnight in 80% ethanol. The cells were scraped and debris was removed 
by centrifugation. The ethanolic supernatants were evaporated and the resi- 
due resuspended in 0.05 M Tris--4 mM EDTA, pH 7.5. cAMP content was 
estimated using a specific radioimmunoassay kit (Amersham International). 
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Figure 3.  Effect of leukoregulin on PGFa production by confluent 
and  proliferating  human  dermal  fibroblasts.  Fibroblast  cultures 
were  incubated  as  described in  Materials  and  Methods  with  or 
without  1  U/ml  LR.  PGE2  was  assayed  by  RIA  in  the  culture 
medium at different time points. Results, expressed as nanograms 
of PGE2 per well, are the mean of triplicate determinations. 
Cell Enumeration and pH]thymidine Incorporation 
For cell enumeration, the cells were washed with PBS, detached with trypsin 
(0.25 %) and counted in an electronic counter (Hycell Inc., Houston, TX). 
DNA replication was estimated as follows. Nonconfluent and confluent 
fibroblast cultures were incubated with or without 1 U/ml LR for different 
time periods. [3H]thymidine (2/~Ci/ml) was either added at the beginning 
of the incubation or during the last 6 h. Cells were then washed three times 
with cold PBS and blocked by the addition of cold 5 % TCA overnight. The 
cell layers were washed three times with 5% "IV_A and dissolved in 0.2 N 
NaOH before measurement of [3H]thymidine incorporation by liquid scin- 
tillation. 
Cytokine Antibodies 
Rabbit anti-human IL-lc~ and anti-human TNF-c~, sheep anti-human IL-1/~, 
and  mouse  anti-human  IFN-3,  were  immunoglobulins  G1  purified  by 
caprylic acid precipitation. 
Each antibody was added to the culture media either alone or in combina- 
tion with its corresponding recombinant antigen (cytokine) as a control of 
its  neutralizing  activity,  and  together with  LR  in  order to  ensure  the 
specificity of LR action on fibroblast collagen synthesis. 
Statistical Analysis 
All the results presented are expressed as mean  +  SD unless indicated 
otherwise. Student's t test was used to evaluate the difference of the means 
between groups. 
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Effect of  Leukoregulin on lqbroblast 
Collagen Synthesis 
The effect of leukoregulin on fibroblast collagen synthesis 
was tested by three alternative methods: incorporation of 
[3H]proline into collagenase-sensitive  peptides, SDS-PAGE, 
and radioimmunoassay. Fig. 1 illustrates the effect of  0.1, 0.5, 
1,  5,  and  10  U/ml of human LR on the incorporation of 
[3H]proline into collagen and noncollagenous protein in the 
culture medium during a 24-h incubation of  confluent human 
dermal fibroblasts. LR exerted a dose-dependent inhibition 
of collagen synthesis (Fig. 1 A). Maximal inhibition by LR 
(-50%, P < 0.001) was observed at 5 U/ml and then reached 
a plateau. In contrast, the production of noncollagenous pro- 
tein was only slightly reduced (maximum -24 %, P <  0.01, 
Fig.  1 B). No alteration in cell morphology was observed 
with phase contrast microscopy when cells were treated with 
LR; moreover, trypan blue exclusion revealed no change in 
cell membrane permeability, even with 10 U/mi LR. 
To estimate the kinetics of LR-induced decrease of colla- 
gen production, the cells were incubated with or without 
1 U/ml LR and [3H]proline  incorporation into collagenase 
digestible protein was measured at different time points (6, 
12, 24, 48, and 72 h). The inhibitory effect exerted by LR 
could be detected as early as 6 h after addition of the cyto- 
kine (-30%, P<0.01). This inhibitory effect of LR could not 
be attributed to an inhibition of cell proliferation by LR since 
neither cell counts nor [3H]thymidine  incorporation during 
these incubation periods revealed any significant difference 
between control and LR-treated cultures (not shown). 
The inhibitory effect of LR on the amounts of secreted col- 
lagen as measured by assay of collagenase-sensitive protein 
was  confirmed by the  electrophoretic analysis of pepsin- 
resistant material (Fig. 2 A). Densitometric analysis of the 
fluorographs showed inhibition of both type I and I/I colla- 
gen. The amounts of newly synthesized procollagens present 
in the medium were also reduced by LR (Fig. 2 B), suggest- 
ing that the inhibition of collagen synthesis is not due to a 
modification  of  the maturation of  precursor molecules. More- 
over, this effect is also not due to an impaired secretion since 
no parallel accumulation of  collagen in the cell layer could be 
detected after LR treatment (not shown). Fibronectin produc- 
tion was also reduced, in both secreted and cell-associated 
fractions. In contrast, the synthesis of otl(V) collagen chains, 
as revealed on fluorographs obtained after a long time ex- 
posure of the gels, was almost unaffected  by LR (not shown). 
Inhibition of collagen synthesis by LR was further con- 
firmed by specific radioimmunoassay. The extent of inhibi- 
tion reached 39 % (P < 0.02) for type I collagen and 32 % (P 
< 0.05) for type rll collagen after 24 h incubation with 1 U/ml 
LR. These data obtained with a labeling-independent quan- 
titative method exclude the possibility of an altered intracel- 
lular pool of proline by LR that would result in the dilution 
of the isotopes and to a subsequent decreased incorporation 
into protein. 
To be sure that the effect of LR was not due to a contamina- 
tion of the preparation by other cytokines, we used antibod- 
ies  against  IL-lu,  IL-lfl,  TNF-ot,  and  IFN-  7,  the  major 
cytokines cytokines known to decrease fibroblast collagen 
production in vitro (Jimenez et al.,  1984;  Mauviel et al., 
1988a, 1991). As can be seen in Table I, the antibodies neu- 
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Figure 4. Effect of leukoregulin on intracellular cyclic AMP levels 
in confluent and proliferating human dermal fibroblasts. Fibroblast 
cultures were incubated as described in Materials and Methods 
with or without 1 U/ml LR. Intracellular cAMP was assayed  in par- 
allel to PGE2 production (Fig. 3). Results, expressed as picomoles 
of  cAMP per dish, are the mean + SD of triplicate determinations. 
tralized the effect of their respective antigens (cytokines) but 
failed to block the inhibition exerted by LR, supporting the 
specificity of LR inhibition of fibroblast collagen synthesis. 
Effects of  Leukoregulin on Prostaglandin E2 and Cyclic 
AMP Production by Fibroblasts 
To investigate the mechanism of fibroblast activation by LR, 
and to determine if the inhibition of collagen synthesis could 
be related to arachidonate metabolism, we assayed the ac- 
cumulation of PGFa in the culture medium in relation to in- 
tracellular cyclic AMP contents. 
As can be seen in Fig. 3, LR (1 U/ml) markedly enhanced 
PGF_~ production by fibroblasts, in both confluent (Fig. 3 A) 
and nonconfluent cultures (Fig. 3 B), with a maximal effect 
during the first 12 h. PGE2 was increased >10 times after 
6 h stimulation by LR. LR also induced a transient rise in 
intracellular cAMP  (Fig.  4),  with a  peak at 6  h  in both 
confluent (Fig. 4 A) and nonconfluent (Fig. 4 B) cultures. 
Since the depression of collagen synthesis induced by LR 
occurred concomitantly with a very large increase of PGFa 
released into the culture medium, and since PGE2 has been 
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Figure 5. Effect of leukoregulin on total glycosaminoglycan pro- 
duction by human dermal fibroblasts. Confluent cells were labeled 
for 24 h with [~H]glucosamine  as described in Materials and Meth- 
ods. GAG radioactivity was estimated as dpm in pronase-digested 
CPC precipitated material present in the culture medium. Results 
expressed as dpm x  10-3/dish are the mean :i: SD of quadrupli- 
cate assays. (a) P < 0.05; (b) P < 0.02; (c) P < 0.01. 
reported to inhibit fibroblast collagen synthesis (Varga et al., 
1987), we studied the effect of 1 U/ml LR in the presence 
of 10/~M indomethacin, a concentration known to almost to- 
tally abolish fibroblast prostaglandin synthesis (Mauviel et 
al., 1988b). Indomethacin did not however reduce the inhibi- 
tory effect of LR on collagen synthesis (not shown), suggest- 
ing that this effect of LR is not prostaglandin dependent. 
Effect of Leukoregulin on Fibroblast 
Glycosaminoglycan  Synthesis 
Treatment of fibroblasts over a 24-h period with various con- 
centrations of LR resulted in a significant increase in [3H]- 
glucosamine incorporation into GAG secreted in the medium, 
which represent about 90%  of total GAG synthesized by 
fibroblasts (Fig. 5). 0.05 U/ml LR was sufficient to markedly 
augment GAG production (+30%, P < 0.02). A dose-depen- 
dent increase was observed and 5 U/ml led to twofold greater 
[3H]glucosamine incorporation than in control cultures (P 
<  0.001). 
To characterize the types of proteoglycans synthesized in 
the presence of LR, fibroblasts were incubated with pH]- 
glucosamine and [35S]sulfate, in presence or absence of 0.1 
U/ml LR, a  concentration shown to increase by 80%  the 
[3H]glucosamine incorporation into cetylpyridinium chlo- 
ride-precipited GAG (Fig. 5). Ion-exchange chromatography 
profiles of secreted proteoglycan eluted from DEAE-Sepha- 
eel show that LR strongly augmented [3H]glucosamine in- 
corporation in a peak eluting at 0.2 M NaCI (Fig. 6) which 
was  sensitive to hyaluronidase digestion (not shown) and 
thus corresponds to hyaluronic acid. The incorporation of 
[3H]glucosamine into glycoproteins ehited with the starting 
buffer was also strongly stimulated by LR. In contrast, p~S]- 
sulfate incorporation into secreted sulfated GAG (eluted at 
0.5 M  NaC1) was almost unaltered by LR. 
Effect of  Leukomgulin on Extr~ellular 
Protease Activities 
To determine the eventual role of LR on catabolic functions 
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Figure 6. Ion-exchange chromatography profiles of proteoglycans 
secreted by control and leukoregulin-treated human dermal fibro- 
blasts. Confluent cells were labeled for 24 h with [3H]glucosamine 
and  [35S]SO4 as described  in  Materials  and Methods.  Samples 
were applied to DEAE-Sephacel columns equilibrated with 0.1 M 
Tris-7 M urea pH 7.5, and eluted by a 0-I-M NaC1 gradient. Radio- 
activity of 0.4-ml fractions was counted by liquid scintillation. 
of fibroblasts,  media  from  LR-treated fibroblast cultures 
(1  U/m1 during 24 h) were tested for protease activities. 
A  time course of fibroblast secreted proteases was ana- 
lyzed by SDS-substrate PAGE using gelatin as a substrate 
(gelatin zymogram). Gelatinolytic activity was detected as 
cleared bands against the stained gelatin background. As can 
be seen in Fig. 7, the major protease activity appearing in 
control cultures was ~70 kD, corresponding to 72-kD pro- 
gelatinase (Overall et ai.,  1989). Two pairs of bands were 
also  detected,  the  larger  ~100-110  kD,  which  may  cor- 
respond to the native form of the 72-kD progelatinase (Over- 
all et al.,  1989), and the smaller ~45-50 kD, which corre- 
sponds to both stromelysin or interstitial 45-kD collagenase, 
even if the ability of these two enzymes to degrade gelatin 
substrates is limited (Chin et al., 1985; Okada et al., 1986). 
A faint band of '~ 30 kD was detected, corresponding to a 
subtype of stromelysin (Okada et al.,  1986). Treatment of 
fibroblasts with 1 U/ml LR led to an increased expression 
of  both 45- and 30-kD protease activities, which could be de- 
tected after 6  and  12 h,  respectively. No increase in the 
amount of the 70- and 110-kD proteases was observed. 
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fibroblasts. Confluent  fibroblast  cultures were incubated for various 
time periods with or without 1 U/ml LR. 50-td aliquots of superna- 
tants were fractionated electrophoretically in a 11% acrylamide gel 
containing 1 mg/ml gelatin and tested for their gelatinase activity 
as described in Materials and Methods. 
To further characterize the action of LR, we measured col- 
lagenase and neutral protease activities in fibroblast super- 
natants  by the  degradation of 3H-acetylated-collagen and 
casein. Elastase activity was quantified using the synthetic 
substrate Suc(AIa)3NA.  As can be seen in Table II, all these 
proteases activities were augmented approximately to the 
same extent (from +20 to  +3Q%, P  <  0.01) by LR. 
Discussion 
The present study demonstrates for the first time that leu- 
koregulin can modulate several functional aspects of fibro- 
blast biology, including components central to the synthesis 
and degradation of the extracellular matrix. LR is a 50-kD 
lymphokine that was originally identified as a protein dis- 
playing specific regulatory activities for cells undergoing 
transformation to the neoplastic state or for fully neoplastic 
cells. Several in vitro and in vivo studies have provided evi- 
dence that ECM metabolism is controlled by a number of 
cytokines and growth factors acting on mesenchymal cells 
such as fibroblasts. Some of the mediators are produced by 
activated lymphocytes and macrophages present at the sites 
of inflammation or  would repair.  For  example,  IL-1  and 
TNF-ot have been shown to induce production of collagenase 
by dermal fibroblasts or rheumatoid synovial cells, and to in- 
hibit their collagen production (Mizel et al., 1981; Dayer et 
al.,  1985;  Mauviel et al.,  1988a,  1988c,  1991). Similarly, 
IFN-'t has been described as a potent inhibitor of collagen 
synthesis (Jimenez et al.,  1984).  On the other hand, it has 
been  reported  that  TGF-/3 can  stimulate the  synthesis of 
ECM components in mesenchymal cells,  including fibro- 
blasts  (Ignotz and  Massagut,  1986;  Fine and  Goldstein, 
1987).  It is likely that these mediators are acting in con- 
cert in vivo as elements of a balanced homeostatic network. 
Their relative amount of efficiency probably varies depend- 
ing on  whether matrix deposition  is  required  in  various 
remodeling situations such as wound healing. The interac- 
tions between these connective tissue modulating proteins 
however remain to be elucidated. 
The in vitro results presented here strongly suggest that 
leukoregulin can be classified as a lymphokine capable of 
modulating the metabolism of  the major matrix components, 
collagen  and  glycosaminoglycans, in  dermal  fibroblasts. 
Leukoregulin inhibits both collagen and fibronectin synthe- 
sis and stimulates hyaluronic acid production. Furthermore, 
LR enhances release of PGF_a, collagenase, and neutral me- 
talloprotease activities. Similar responses are observed with 
IFN-% IL-1, and TNF-ct (Jimenez et al.,  1984;  Mauviel et 
al.,  1991). However, the inability of neutralizing antibodies 
against these cytokines to alter the LR action clearly demon- 
strates the specificity of LR action. Since dermal fibroblasts 
have been shown to express IL-1 and TNF-a mRNAs in cul- 
ture, especially when they are exposed to exogenous IL-1 
(Mauviel et al.,  1988d,  1991), the question arises whether 
the observed effects  may be due to LR-induced synthesis 
of these cytokines by fibroblasts. This is, however, also un- 
likely since the addition of neutralizing antibodies against 
IL-1  and TNF-a failed to block the inhibition of collagen 
synthesis by LR. 
The molecular pathways whereby LR exerts its action on 
collagen and hyaluronic acid synthesis are not known. Our 
results  obtained  with  the  cyclooxygenase inhibitor  indo- 
methacin clearly indicate that the enhancement of PGEa re- 
lease upon LR treatment cannot be responsible for these 
effects.  Further studies are required to determine whether 
LR directly affects collagen synthesis at the transcriptional 
level as has been shown for IL-1 and TNF-ot (Goldring and 
Krane,  1987; Solis-Herruzo et al.,  1988;  Mauviel et al., 
1988c,  1991; Khh/iri et al.,  1990).  We might anticipate that 
LR will also affect the synthesis of collagen and extracellular 
Table 11. Effect of  Leukoregulin on Fibroblast Proteolytic Activities 
Caseinase activity  Collagenase activity  Elastase activity 
(hydrolysis of 3H-acetylated  casein)  (hydrolysis of 3H-acetylated  collagen)  (hydrolysis of Suc(AIa)3N A) 
/zg substrate/h/ml  /zg substrate/h/ml  nmol substrate/h/ml 
Control  4.1  +  0.1  (100  +  2)  3.2  +  0.2  (100  +  6)  14.8  +  0.7 (100  -1- 4) 
LR (1  U/ml)  4.9  +  0.2  (120  +  5)*  4.3  +  0.2  (134  +  6)*  18.8  +  0.5  (127  +  4)* 
Confluent fibroblasts in 75-cm  2 flasks were incubated for 24 h in presence or absence of 1 U/nil LR (6 rnl medium). Proteolytic activities were determined in 
the culture medium as described in Materials and Methods. Results are the mean +  SD of triplicate  samples. % of respective controls are indicated in parentheses. 
* P  <  0.02. 
~ P  <  0.001. 
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been  shown to upregulate  transcription  of class  I  and !1 
histocompatibility antigens while simultaneously inhibiting 
human papilloma virus early  gene transcription  in human 
cervical epithelial  cells (Woodward et al.,  1990). 
This investigation  demonstrates  that LR is a protein with 
the ability to modulate both anabolic and catabolic functions 
of fibroblasts.  Moreover,  the induction of PGE2 release  by 
connective tissue cells also suggests that LR may have pro- 
inflammatory  properties.  This is the first demonstration  for 
a potential  role of this cytokine in the regulation  of several 
functions of nontransformed nonmalignant cells that are cen- 
tral to tissue remodeling and to the inflammatory  process. 
LR may be a member of a family of leukocyte-derived  cyto- 
kines that control connective tissue formation or remodeling 
and that participate in a number of dermatological disorders 
in which leukocyte infiltrates are present  including  dermal 
fibrosis,  keloid scars,  and scleroderma. 
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